Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Differential articular calcified cartilage and subchondral bone in postmenopausal women with osteoarthritis and osteoporosis: Two-dimensional analysis
Joint, Bone, Spine, 08/24/09
Zhang ZM et al. – Study demonstrates that the pathogenesis of osteoarthritis (OA) and osteoporosis (OP) were influenced by differential properties of articular calcified cartilage (ACC) and subchondral bone microstructure. Structural properties of the subchondral mineralized tissue supported that an inverse relationship existed between postmenopausal women with OA and OP.
Methods- A comparison of the structural properties of ACC and subchondral bone between postmenopausal women with OA and OP
- 8 femoral heads taken from postmenopausal women during total hip replacement surgery due to primary OA
- They were compared with 9 femoral heads obtained from age-matched women with OP during hemi-hip arthroplasty surgery due to osteoporotic fracture
- 2D histomorphometric sections were prepared to measure the thickness of ACC and bone histomorphometric parameters
- Ratio of ACC to the total articular cartilage (TAC) was also calculated in all bone specimens
- Osteoarthritic donors had higher ACC and the ratio of ACC to TAC
- Lower bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N) and the ratio of nodes to termini (Nd/Tm) were demonstrated in donors with OP
- However, trabecular space (Tb.Sp) increased in these osteoporotic pts
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Sponsor
Article Search
Sponsor


See Latest Articles


